Novartis ‘always looking’ for new ways to shuttle drugs to brain
Novartis may be launching an array of vehicles to shuttle drugs across the blood-brain barrier, but executives told…
Regulatory round-up: Novartis, Sanofi and Arrowhead secure CHMP blessings
The European drug market could soon be poised to receive three new entries, as the European Committee for…
Oligonucleotides Market Research and Competitive Landscape Report 2026 Featuring Novartis, Astellas, Alnylam Pharmaceuticals, Ionis Pharmaceuticals
Company Logo Key opportunities in the oligonucleotide market include advancing therapeutics for rare and diverse diseases like neurodegenerative…
Arrowhead Pharmaceuticals Announces Closing of Global License and Collaboration Agreement with Novartis
PASADENA, Calif., October 21, 2025–(BUSINESS WIRE)–Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that a global licensing and collaboration…